Drug Database
Back to search

Finland· FI-REL-REL23086

Laxoberon

A sodium picosulfate product containing sodium picosulfate, registered in Finland by Orifarm Oy. The same ATC class is registered in 12 of our 19 countries.

ATC A06AB08

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedLaxoberonATCA06AB08REGISTER NO.FI-REL-REL23086PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sodium picosulfateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sodium picosulfate is registered in 12 of 19 countries.

Countries holding a registration under ATC A06AB08 (sodium picosulfate), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 7 of them publish a price we can compare per daily dose
Search sodium picosulfate products by name

Sodium picosulfate · ATC A06AB08

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Sodium picosulfate
Manufacturer
Orifarm Oy
Country
Finland (FI)
ATC code
A06AB08
ATC class
Sodium picosulfate
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

516 interactions on record for sodium picosulfate.

Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check sodium picosulfate against other medicinesHow interaction checks work

Sodium picosulfate · interactions on record

516 records

  • 37 severe
  • 475 moderate
  • 4 minor

Most severe, free to view

  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • ProcainamideC01BA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sodium picosulfate in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sodium picosulfate products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Agaffin, Guttalax
  • Belgium · Dulcolax Picosulphate, Fructines
  • Bulgaria · Глицеракс Пико, Дулколакс Пико
  • Czechia · Gallax, Guttalax
  • Germany · Dulcolax Np Perlen, Dulcolax Np Tropfen
  • Denmark · Actilax, Laxoberal
  • Estonia · Guttalax, Regulax
  • Spain · Dulcolax Picosulfato, Evacuol
  • France · Fructines
  • United Kingdom (Northern Ireland) · Dulcolax Adult Pico Liquid, Dulcolax Adult Pico Perles
  • Greece · Dulcoflex
  • Hungary · Dulcolax, Stadalax
  • Ireland · Dulcolax Pico Liquid
  • Iceland · Laxoberal
  • Italy · Euchessina C.M., Gocce Lassative Aicardi
  • Lithuania · Regulax
  • Luxembourg · Laxoberon
  • Latvia · Guttalax, Regulax
  • Malta · Dulcolax Pico Liquid
  • Norway · Laxoberal
  • Poland · Pikopil
  • Portugal · Dulcolax Gotas, Enterex
  • Romania · Dulcopic
  • Sweden · Cilaxoral, Laxoberal
  • Slovakia · Guttalax, Laxygal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f276ee4a-3705-4a1b-82b7-316d663ffb74
GET /v1/drugs/f276ee4a-3705-4a1b-82b7-316d663ffb74?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "5",
  "form": "tipat, liuos",
  "route": null,
  "ddd_unit": "mg",
  "strength": "7.5 mg/ml",
  "atc_label": "natriumpikosulfaatti",
  "ma_number": "20371",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL23086",
  "authorised_at": "2007-09-20"
}
API referenceMCP serverPlans

See everything about sodium picosulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console